ENPP2 and COVID-19: No correlation of ATX serum levels with the related underlying comorbidities of COVID-19 patients, cardiovascular diseases, diabetes, and dyslipidemia (Figure S1B) or the body mass index (BMI; data not shown) of patients was observed.